ID

27536

Beschreibung

Study Part: Study Conclusion Follow- Up (Visit 10). An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Stichworte

  1. 19.11.17 19.11.17 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

19. November 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Study Conclusion Follow- Up (Visit 10) Ropinirole Parkinson Disease 101468/165

Study Conclusion Follow- Up (Visit 10)

STUDY CONCLUSION
Beschreibung

STUDY CONCLUSION

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
Subject Number
Beschreibung

Subject Number

Datentyp

text

Alias
UMLS CUI [1]
C2348585
Did the subject complete the study as planned?
Beschreibung

Study Conclusion

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1707478
UMLS CUI [1,2]
C0008972
If ’NO’, mark the one most appropriate category
Beschreibung

Study Conclusion

Datentyp

integer

Alias
UMLS CUI [1,1]
C1707478
UMLS CUI [1,2]
C0008972
Other, Please specify
Beschreibung

Other

Datentyp

text

Alias
UMLS CUI [1]
C0205394
Comments on reason for withdrawal:
Beschreibung

Comment reason for withdrawal

Datentyp

text

Alias
UMLS CUI [1,1]
C0947611
UMLS CUI [1,2]
C2349954
UMLS CUI [1,3]
C0392360
UMLS CUI [1,4]
C0008976
Date of Withdrawal:
Beschreibung

Date of Withdrawal

Datentyp

date

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0011008
Time of Withdrawal:
Beschreibung

Time of Withdrawal

Datentyp

time

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0040223
Date of Final Dose:
Beschreibung

Date of Final Dose

Datentyp

date

Alias
UMLS CUI [1]
C1531784
Time of Final Dose:
Beschreibung

Time of Final Dose

Datentyp

time

Alias
UMLS CUI [1]
C0946444

Ähnliche Modelle

Study Conclusion Follow- Up (Visit 10)

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
STUDY CONCLUSION
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Subject Number
Item
Subject Number
text
C2348585 (UMLS CUI [1])
Study Conclusion
Item
Did the subject complete the study as planned?
boolean
C1707478 (UMLS CUI [1,1])
C0008972 (UMLS CUI [1,2])
Item
If ’NO’, mark the one most appropriate category
integer
C1707478 (UMLS CUI [1,1])
C0008972 (UMLS CUI [1,2])
Code List
If ’NO’, mark the one most appropriate category
CL Item
Adverse Event (complete Adverse Event Form) (1)
C0877248 (UMLS CUI-1)
(Comment:en)
CL Item
Insufficient therapeutic effect (2)
C1527144 (UMLS CUI-1)
(Comment:en)
CL Item
Deviation from Protocol (including non-compliance) (3)
C1321605 (UMLS CUI-1)
(Comment:en)
CL Item
Lost to Follow-Up (4)
C1302313 (UMLS CUI-1)
(Comment:en)
CL Item
Other (5)
C0205394 (UMLS CUI-1)
(Comment:en)
Other
Item
Other, Please specify
text
C0205394 (UMLS CUI [1])
Comment reason for withdrawal
Item
Comments on reason for withdrawal:
text
C0947611 (UMLS CUI [1,1])
C2349954 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,4])
Date of Withdrawal
Item
Date of Withdrawal:
date
C2349954 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Time of Withdrawal
Item
Time of Withdrawal:
time
C2349954 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
Date of Final Dose
Item
Date of Final Dose:
date
C1531784 (UMLS CUI [1])
Time of Final Dose
Item
Time of Final Dose:
time
C0946444 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video